# ERMEZA
> **NDA215809** · New Drug Application · Sponsor: MYLAN · Approved 2022-04-29
## Drug
- **FDA Application Number:** NDA215809
- **Application type:** New Drug Application
- **Brand name:** ERMEZA
- **Generic name:** LEVOTHYROXINE SODIUM
- **Active ingredients:** LEVOTHYROXINE SODIUM
- **Dosage form:** SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** MYLAN
- **Manufacturer:** Viatris Specialty LLC
- **First approval:** 2022-04-29
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215809)
---
*AI Analytics · CC0 1.0*